SINOPHARM GROUP CO. LTD. Toevoegen aan een lijst
Financiële vergelijkingen Sinopharm Group Co. Ltd.
Aandelen
1099
CNE100000FN7
Farmaceutische producten
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 16,44 HKD | -2,26% |
|
-9,57% | -19,61% |
| 28/08 | Voorzitter en president van Shyndec Pharmaceutical nemen ontslag | MT |
| 27/08 | Sinopharm Group Co. Ltd. Kondigt een nieuwe voorzitter aan | CI |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Omzet ($) (Y-1) | Nettomarge (Y-1) | Bedrijfsmarge (Y-1) | ROE (Y-1) | ROA (Y-1) | Hefboom (schuld/EBITDA) (Y-1) | |
|---|---|---|---|---|---|---|---|
| 84,16 mld. | +1.52% | +3.39% | +12.69% | +2.42% | 0.54x | ||
| 309 mld. | +0.97% | +1.59% | - | +5.67% | 0.2x | ||
| 227 mld. | +0.38% | +1.06% | - | +4.20% | -0.01x | ||
| 36,72 mld. | +1.45% | +2.95% | +5.56% | +1.84% | 1.24x | ||
| 5,73 mld. | +6.99% | +8.50% | +13.96% | +8.78% | -0.71x | ||
| 2,96 mld. | +11.50% | +16.05% | +10.70% | +6.12% | -0.13x | ||
| 4,45 mld. | +7.62% | +5.11% | +21.01% | +10.18% | 2.72x | ||
| 8,95 mld. | +2.06% | +3.96% | +12.42% | +4.60% | 1.63x | ||
| 25,04 mld. | +1.17% | +1.33% | +7.10% | +3.69% | -3.53x | ||
| 21,18 mld. | +1.45% | +2.01% | +9.04% | +2.35% | -0.63x | ||
| 7,01 mld. | +4.32% | +5.92% | +13.68% | +6.92% | - | ||
| 16,79 mld. | +1.22% | +1.46% | +7.00% | +3.23% | -5.57x | ||
| 10,39 mld. | +1.40% | +1.31% | +8.40% | +2.93% | -4.02x | ||
| 10,65 mld. | +2.12% | +3.27% | +9.56% | +3.55% | -0.99x | ||
| 1,06 mld. | +6.69% | +8.98% | +22.82% | - | - | ||
| 2,22 mld. | +0.14% | +0.95% | +0.67% | +0.35% | -5.97x | ||
| 2,87 mld. | +0.23% | - | +1.48% | +0.53% | - | ||
| 11,3 mld. | +0.82% | +1.26% | +5.98% | +1.09% | - | ||
| Gemiddelde | 43,74 mld. | +2,89% | +4,06% | +10,13% | +4,02% | -1,09x | |
| Gewogen gemiddelde per kap. | 181 mld. | +2,04% | +2,97% | +10,81% | +4,97% | -0,07x |
- Beurs
- Aandelen
- Koers 1099
- Sector Sinopharm Group Co. Ltd.
- Financiële vergelijkingen
